IP Library › Patent Application 18987004
Patent Application
App. No. 18/987,004

Retroviral and Lentiviral Vectors

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/987,004
Abstract

The present invention provides a retroviral or lentiviral vector having a viral envelope which comprises: (i) a mitogenic T-cell activating transmembrane protein which comprises a mitogenic domain and a transmembrane domain; and/or (ii) a cytokine-based T-cell activating transmembrane protein which comprises a cytokine domain and a transmembrane domain, wherein the mitogenic or cytokine-based T-cell activating transmembrane protein is not part of a viral envelope glycoprotein. When cells such as T-cells of Natural Killer cells are transduced by such a viral vector, they are simultaneously activated by the mitogenic T-cell activating transmembrane protein and/or the cytokine-based T-cell activating transmembrane protein.

Claims (16)

1 .- 26 . (canceled)

27 . A kit for making a retroviral or lentiviral vector having a viral envelope that comprises a first mitogenic T-cell activating transmembrane protein which comprises a mitogenic domain which binds CD3 and comprises a transmembrane domain, and a second mitogenic T-cell activating transmembrane protein which comprises a mitogenic domain which binds CD28 and comprises a transmembrane domain, the kit comprising:

(a) a host cell which expresses at the cell surface, the first and second mitogenic T-cell activating transmembrane proteins, wherein the mitogenic T-cell activating transmembrane proteins are not part of a viral envelope glycoprotein,

(b) nucleic acids comprising gag, pol, env and optionally rev, and

(c) a retroviral or lentiviral genome.

28 . A kit for making a packaging cell which comprises:

(a) one or more nucleic acid(s) encoding:

(i) a first mitogenic T-cell activating transmembrane protein which comprises a mitogenic domain which binds CD3 and comprises a transmembrane domain and

(ii) a second mitogenic T-cell activating transmembrane protein which comprises a mitogenic domain which binds CD28 and comprises a transmembrane domain, wherein the mitogenic T-cell activating transmembrane proteins are not part of a viral envelope glycoprotein, and

(b) nucleic acids comprising retroviral gag, pol, env and optionally rev genes.

29 . A kit for making a producer cell which comprises:

(a) one or more nucleic acid(s) encoding:

(i) a first mitogenic T-cell activating transmembrane protein which comprises a mitogenic domain which binds CD3 and comprises a transmembrane domain and

(ii) a second mitogenic T-cell activating transmembrane protein which comprises a mitogenic domain which binds CD28 and comprises a transmembrane domain, wherein the mitogenic T-cell activating transmembrane proteins are not part of a viral envelope glycoprotein,

(b) nucleic acids comprising retroviral gag, pol, env and optionally rev genes, and

(c) a retroviral or lentiviral vector genome.

Assignments (4)
PATENT SECURITY AGREEMENT Recorded Jul 30, 2026
From: AUTOLUS LIMITED
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 076084/0283 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2025
From: PULÉ, MARTIN; MEKKAOUI, LEILA
To: UCL BUSINESS PLC
Reel/Frame 070788/0324 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2025
From: UCL BUSINESS LTD
To: AUTOLUS LIMITED
Reel/Frame 070788/0634 →
CHANGE OF NAME Recorded Apr 9, 2025
From: UCL BUSINESS PLC
To: UCL BUSINESS LTD
Reel/Frame 070793/0650 →